As PPARγ is a significant drug target for metabolic syndrome associated with obesity-induced insulin resistance and hyperglycemia31, 32, we used the db/db diabetic mouse model and their littermates to determine whether chelerythrine has the ability to improve glucose homeostasis in these mice. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.